- $4.32bn
- $4.10bn
- $1.39bn
Brief: LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
LivaNova PLC reports results for the quarter ended in March - Earnings Summary
Brief: LivaNova Q1 Adjusted EPS USD 0.73 Vs. IBES Estimate USD 0.49
LivaNova PLC expected to post earnings of 49 cents a share - Earnings Preview
Brief: LivaNova PLC Says Providing Notice To U.S. Patients Regarding A Cybersecurity Incident That Was Initially Disclosed By Co On Nov 20, 2023
U.S. STOCKS ON THE MOVE-Enservco, Citigroup, Tencent
U.S. STOCKS ON THE MOVE-J.Jill, LivaNova, International Paper
LivaNova climbs on high chance of trial success for sleep apnea device
Brief: Livanova Announces Pricing Of Private Offering Of $300 Million Of 2.50% Convertible Senior Notes Due 2029
LivaNova PLC reports results for the quarter ended in December - Earnings Summary
Brief: LivaNova Q4 Adjusted EPS USD 0.87 Vs. IBES Estimate USD 0.77
Brief: LivaNova to Wind Down Advanced Circulatory Support Business Unit
Brief: Livanova PLC SEC filing Provides Update On Operations With Respect To Cybersecurity Incident
LivaNova PLC reports results for the quarter ended in September - Earnings Summary
Brief: LivaNova Q3 Adjusted EPS USD 0.73 Vs. IBES Estimate USD 0.64
LivaNova PLC expected to post earnings of 64 cents a share - Earnings Preview
Brief: Livanova Says Determined To Extend Term Of William A. Kozy's Employment As Interim CEO
Livanova Board Will Be Comprised Of 10 Directors Until Saia's Retirement At End Of Year
U.S. STOCKS ON THE MOVE-eBay, Teleflex,